- US12550890utility2026System and Method for Maintaining Organ Viability0 cites
- US12491170utility2025Stable Treprostinil Prodrugs0 cites
- US12397895utility2025Structural Features of a Vehicle Having Utility to Transport High Value Things0 cites
- US12310992utility2025Treatment of Pulmonary Arterial Hypertension with Prostacyclin-treated Endothelial Progenitor Cells0 cites
- US12274684utility2025Treatment of Vasculopathy with Prostacyclin and Mesenchymal Stem Cells0 cites
- US12173021utility2024Treprostinil Prodrugs0 cites
- US12168071utility2024Treprostinil Derivatives and Their Use in Pharmaceutical Compositions0 cites
- US12162853utility2024Synthesis of Esuberaprost Prodrugs0 cites
- US12097028utility2024Drug Delivery Device with Electrically Controlled Volume Changing Means0 cites
- US12098116utility2024Crystalline Prostacyclin (IP) Receptor Agonist and Uses Thereof0 cites
- US12017989utility2024Controlled Release Pharmaceutical Formulations0 cites
- US11839596utility2023Treatment of Vasculopathy with Prostacyclin and Mesenchymal Stem Cells0 cites
- US11839631utility2023Treatment of Pulmonary Arterial Hypertension with Prostacyclin-treated Endothelial Progenitor Cells0 cites
- US11826327utility2023Treatment for Interstitial Lung Disease0 cites
- US11826328utility2023Stable Treprostinil Prodrugs0 cites
- US11730710utility2023Treatment for Interstitial Lung Disease0 cites
- US11723887utility2023Process to Prepare Treprostinil, the Active Ingredient in Remodulin®0 cites
- US11672775utility2023Treprostinil Prodrugs0 cites
Page 1 of 2Next →